Abstract:The term premedication, which should really be pre-operative medication, became popular in the 1920s to describe the practice of pre-operative administration of drugs in order to facilitate the induction, maintenance and recovery from general anaesthesia; the latter was usually provided in those days by the inhalational agents chloroform or ether. The advent of rapidly acting intravenous induction agents has revolutionised the induction of anaesthesia, although the incidence of unwanted side effects exhibited by some of them, for example, methohexitone and in particular etomidate, can be influenced by administration of drugs such as phenothiazines, opiates and anticholinergics in the pre-operative period. The introduction of the muscle relaxants led to the concept of balanced anaesthesia. Hypnosis is nowadays maintained by small concentrations of potent inhalational agents or continuous infusions of pharmacokinetically suitable intravenous drugs. A large number of opioid drugs are now available to provide the analgesic component of the technique. The use of such specific agents has allowed the anaesthetist greater control over physiological variables than earlier and this approach has led to improved recovery with analgesia extended into the recovery phase. In the context of contemporary practice, we therefore have to ask, why d o we give pre-operative medication? The anaesthetist wants each patient to arrive in the anaesthetic room in a calm and tranquil state without a tachycardia. In order to achieve this effect sedatives, or analgesics if the patient is in pain, may have to be administered. The use of such agents should not cause severe hypotension, but the vasodilatation commonly produced facilitates venous access. Patients expect to be free of anxiety and pain in the immediate pre-operative period, but anxiety is a complex subjective response which may be difficult to detect. One report’ detected a 60% incidence of anxiety when 500 in-patients were assessed both subjectively and objectively; there were many and varied reasons for this anxiety. The importance of the pre-operative visit cannot be overemphasized. In addition to assessment of the patient’s physical status, it gives the anaesthetist the opportunity to try to assess the degree of anxiety and to determine what can be done about it. The placebo effect of this visit has been confirmed on many occasions. The patient is afforded a chance of explanation and reassurance; often that is all that is necessary. Indeed, many patients dislike the effects produced by many drugs. Day case patients in whom pre-operative medication is avoided where possible, because it is known to delay recovery from anaesthesia, demonstrate that this approach works: although it must be noted that these patients are not subjected to as much environmental distress as in-patients. Correct assessment of the needs of an individual is paramount. If apprehension is to be relieved by medication, then the prescriber must consider what combinations of sedation, analgesia and possibly amnesia are best for the patient. Forrest et aI.* found conflicting views between patients’ and anaesthetists’ clinical impressions on the effectiveness of six pre-operative medications used to reduce apprehension. Their plea that all further studies of premedicants should utilize methodology which determined the patients’ own responses to treatment should be noted, as should their question as to whether studies that depended on the evaluation of an outside observer could produce reliable and useful conclusions. In the past, sedation was produced by the use of hypnotics, although relatively few have stood the test of time because of their side effects. The barbiturates never gained popularity in the United Kingdom and the butyrophenones produced extremely unpleasant effects when used on their own. The opiates, however, usually in association with anticholinergic drugs, have been popular since the nineteenth century with both patients and anaesthetists. The criticism of the use of powerful anal-

Charge and Hydrophobicity of Casein Peptides Influence Transepithelial Transport and Bioavailability.

Transport Versus Hydrolysis: Reassessing Intestinal Assimilation of Di- and Tripeptides by LC-MS/MS Analysis

Casein calcium-binding peptides: Preparation, characterization, and promotion of calcium uptake in Caco-2 cell monolayers

Biology of Peptide Transporter 2 in Mammals: New Insights into Its Function, Structure and Regulation

The zinc absorption of the novel peptide-Zn complex in Caco-2 cells: effects of soybean peptides charge and hydrophobicity

Understanding the Transepithelial Transport and Transbilayer Diffusion of the Antihypertensive Peptide Asn-Cys-Trp: Insights from Caco-2 Cell Monolayers and the DPPC Model Membrane

Role of Oligopeptide Transporter PepT2 in Drug Transportation

Transepithelial Transport Characteristics of the Cholesterol- Lowing Soybean Peptide, WGAPSL, in Caco-2 Cell Monolayers

Transport Mechanism of Oligopeptide Transporter PepT1 and Drug Absorption Mediated by PepT1

Bioactive Peptides Isolated from Casein Phosphopeptides Enhance Calcium and Magnesium Uptake in Caco-2 Cell Monolayers

Drugs before anaesthesia

Effect of Cationic Charge Density on Transcytosis of Polyethylenimine

Tocopherol content of seaweed and seaweed meal. 3. Influence of processing and storage on the content of tocopherols, carotenoids, and ascorbic acid in seaweed meal.

Charge of a Transmembrane Peptide Alters Its Interaction with Lipid Membranes

Accidental Deaths Caused by Electricity in Sweden, 1975–2000

Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1

Characterisation of cell-penetrating peptide-mediated peptide delivery

Applications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein Cargos

Transport Mechanisms and Functions of Peptide Transporter 2

Evaluating the capability of soybean peptides as calcium ion carriers: a study through sequence analysis and molecular dynamics simulations

Bioactive peptide release and the absorption tracking of casein in the gastrointestinal digestion of rats